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Objective  To evaluate the potential eff  ects of a 308-km ultra-marathon on bone and cartilage biomarkers.
Method  Venous blood samples were collected at pre-race, 100 km, 200 km, and 308 km checkpoints. Th  e  following 
markers of cartilage damage and bone metabolism were studied: osteocalcin (OC), osteoprotegerin (OPG), and 
calcium, phosphorous, and cartilage oligomeric matrix protein (COMP).
Results  Blood samples were taken from 20 male runners at four different checkpoints. Serum COMP was 
increased by 194.1% (130.7% at 100 km and 160.4% at 200 km). Serum OPG was signifi  cantly increased by 158.57% 
at 100 km and 114.1% at 200 km compared to the pre-race measures. OC was transiently suppressed at 200 km. 
Serum calcium and phosphorous concentrations decreased compared to the pre-race measures.
Conclusion  This study showed that the 308-km ultra-marathon induced several changes, including transient 
uncoupling of bone metabolism, increased bone resorption, suppressed bone formation, and bone turnover and 
had a major impact on cartilage structure.
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INTRODUCTION
  Although the number of ultra-marathon participants 
with distances >200 km is continuously increasing, an 
insuffi   cient amount of research has been reported on the 
effects of long distance running on cartilage structures 
and bone metabolism.
1 Long distance marathons may 
have negative effects on cartilage, bone function, and 
structures and may induce cellular changes such as 
increased cytokines.
2-8 Cartilage oligomeric matrix 
protein (COMP) is a biochemical marker that is known to 
indicate cartilage damage.
2 Eckstein et al.
9 reported that 
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increased exercise loads may lead to patellar cartilage 
deformation with a greater influence from running 
than cycling, walking, or squatting since it loads greater 
pressure on the cartilage.
  MacDougall et al.
10 reported that track and fi  eld athletes 
may have lower bone mineral contents than non-athletes. 
Repeated endurance exercise training may negatively 
influence bone mineral density in athletes. Matsumoto 
et al.
11 reported that the track and field athletes had 
comparatively lower bone mineral density than other 
athletes in a study of changes in bone mineral density 
and metabolism markers. It was also suggested that 
specifi  c exercise characteristics such as type and intensity 
may have a greater or differentiated influence on bone 
changes. It was suggested that a running distance ≤80-
100 km per week may have a positive infl  uence on bone 
metabolism. On the other hand, running a greater 
distance than the threshold may negatively influence 
bone metabolism.
12,13 
  Receptor activator for nuclear factor 66 kB ligand 
(RANKL), a cytokine for osteoclast differentiation and 
activation, and osteoprotegerin (OPG), a soluble receptor, 
were discovered in previous studies.
14 Kerschan-Schindle 
et al.
15 reported a signifi  cant increase in OPG expression 
3 days after a 246-km long term marathon compared to 
pre-race measures.
  Osteocalcin (OC), which is involved in bone calcifi-
cation, is a marker that reflects the late differentiation 
stage of osteoblasts.
16 Frank et al.
17 reported that OC 
significantly decreased in 4 weeks followed by recovery 
to pre-exercise concentrations after 8 weeks of exercise 
intervention using pre-exercise, 4 week, and 8 week OC 
measurements. In addition, calcium decreased in 4 weeks 
and then stabilized at the pre-exercise concentration. In 
contrast, phosphate continuously increased with time. 
  Studies on bone metabolism were limited to pre-
race, post-race, and recovery measurements of bone 
metabolism markers. Th   is particular study observed the 
changes in biochemical markers at every checkpoint 
of the 308-km ultra-marathon. Moreover, the degree 
of cartilage damage was also measured to observe 
the possible correlations with the distance covered by 
the runners. The results of this study will be used to 
recommend an appropriate amount of exercise for ultra-
marathoners by analyzing physical limits, bone turnover 
status, and the degree of cartilage damage.
MATERIAL AND METHODS
Methods
  Subjects and exercise protocol: The subjects of the 
study were male volunteers who participated in a 
transcontinental ultra-marathon in Korea. Th  e  marathon 
participation criterion was previous completion of one 
or more ultra-marathon competitions. Th   e purpose and 
procedure of the study were explained to a total of 160 
runners, 60 of whom enrolled. Questionnaires to gather 
information such as physical characteristics, exercise 
history, and personal information were completed by the 
participants after they signed written consent forms. Of 
the 60 enrollees, 40 were excluded from the study for not 
completing the race. Th   e remaining 20 participants were 
selected as the study subjects (Table 1). The maximum 
arrival time allowed for the 100 km, 200 km, and 308 km 
checkpoints were 16, 39, and 64 hours, respectively. Of 
the 40 excluded subjects, 24, 10, and 6 runners dropped 
out or were eliminated at 0-100 km, 100-200 km, and 
200-308 km, respectively. The starting point of the 308-
km marathon was the Changhoori wharf of Ganghwa 
county, which is located on the west coast, while the 
end point was Kyungpodae Beach, which is located on 
the east coast of the Korean peninsula. The race began 
at 10 PM with an ambient temperature of 16.3
oC. The 
minimum and maximum ambient temperatures were 
13
oC and 31.9
oC, the average wind speed was 1.8 m/
s, and the relative humidity was 51.9%. Drinking water 
was provided at all checkpoints in an effort to prevent 
hemoconcentration. Korean food composed of adequate 
Table 1. Subject Characteristics (n=20)
Variables Mean±SD
  Age (years) 51.5±6.5
  Height (cm) 168.5±5.8
  Body mass index (kg/m
2) 23.1±1.3
  Resting heart rate (bpm) 64.5±8.2
  Maximal heart rate (bpm) 174.5±7.9
  Resting systolic blood pressure (mmHg) 131.1± 8.8
  Resting diastolic blood pressure (mmHg) 81.8±6.7
  VO2 max (ml/kg/min) 48.0±4.8
  Race time (min) 3,691.2±234.3
  100 km ultra-marathon races (number) 6.4±1.6
  Running history (years) 6.9±4.3Kyung-A Shin, et al.
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carbohydrate and protein was provided at 200 km, 250 
km, and 308 km. Additional water and nutrients needed 
by the runners were self-provided during the race.
  Blood collection: Blood was collected before the race 
and at the 100-km, 200-km, and 308-km checkpoints to 
observe the changes in bone metabolism during the race. 
Blood was collected from the antecubital vein according 
to the standard protocol of the Clinical and Laboratory 
Standard Institute. Blood was first collected, placed in 
a BD Vacutainer
® Serum Separator 109 tube (Dickinson 
and Company, Franklin Lakes, USA), and centrifuged for 
10 minutes at 3,400 rpm for serum extraction. Calcium 
and phosphate were immediate analyzed. Th  e  remaining 
samples were stored in a deep freezer at -70
oC and later 
analyzed for COMP, OPG, and OC. 
  Blood analysis: COMP, a bone metabolism marker, 
was analyzed using the enzyme linked immunosorbent 
assay (ELISA) method with a Biovendor R&D kit. OPG 
and OC were analyzed using the enzyme immunoassay 
(EIA) method with a Microvue kit (QUIDEL Co., San 
Diego, USA). Calcium, a biochemical marker for bone 
metabolism, was analyzed using the OCPC (o-cresol-
phthalein complexone) method with a Denka Seiken 
kit (Denka Seiken Co., Tokyo, Japan). Phosphate was 
analyzed using the phosphomolybdate method with 
a Raychem kit (Hemagen Diagnostics Inc., San Diego, 
USA). Biochemical analysis was done using a TBA-200FR 
Auto analyzer (Toshiba, Tokyo, Japan). All measures were 
repeated twice by the same analyzer to verify accuracy.
Statistics
  All descriptive statistics (mean, SD) obtained from this 
study were calculated using SPSS/PC 15.0 statistical 
package for Windows. Repeated analysis of variance 
measures were applied to observe the changes in hema-
tological variables at the pre-race, 100-km, 200-km, and 
308-km checkpoints. Th   e Bonferroni method was applied 
for post hoc analysis for the results with significant 
changes. The statistical significance level was set at 
p<0.05.
RESULTS
Changes in COMP for each checkpoint
  Compared to the pre-race values, COMP at the 100-
km, 200-km, and 308-km checkpoints increased by 
130.7% (p<0.05), 160.4% (p<0.001), and 194.1% (p<0.001), 
respectively. Furthermore, COMP values at 200 km and 
308 km were significantly increased by 122.7% (p<0.05) 
and 148.4% (p<0.05) compared to the COMP value 
at 100 km, respectively. However, a 121.0% increase 
was observed at 308 km compared to 200 km without 
signifi  cance (Fig. 1).
Changes in OPG for each checkpoint
  OPG significantly increased by 158.57% (p<0.001) and 
114.1% (p<0.01) at 100 km and 200 km compared to the 
pre-race OPG. However, a significant change was not 
observed at 308 km with a 106.9% increase. Significant 
Fig. 1. Changes in cartilage oligomeric matrix protein during 
the marathon. a: Signifi  cant diff  erence compared to the pre-
race value; b: signifi  cant diff  erence compared to the 100-km 
value. 
††p<0.001 and 
†p<0.05.
Fig. 2. Changes in osteoprotegerin during the marathon. 
a: Significant difference compared to the pre-race value; 
b: significant difference compared to the 100-km value. 
††p<0.001 and 
†p<0.05.Eﬀ  ect of Ultra-marathon (308 km) Race on Bone and Cartilage
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reductions were observed at 200 km and 308 km by 72.0% 
(p<0.001) and 67.4% (p<0.001) compared to 100 km. An 
insignifi  cant reduction of 93.7% was observed at 308 km 
compared to 200 km (Fig. 2). 
Changes in OC at each checkpoint
  Although OC insignificantly decreased at 100 km by 
79.1%, it significantly decreased at 200 km by 60.3% 
(p<0.05). An insignificant increase of 109.3% was 
observed at 308 km. Furthermore, an insignificant 
reduction of 76.2% was observed at 200 km compared to 
100 km. An insignifi  cant increase of 138.1% was observed 
at 308 km compared to 100 km. Finally, a significant 
increase of 181.3% (p<0.001) was observed at 308 km 
compared to 200 km (Fig. 3).
Changes in calcium level for each checkpoint
  Although the calcium level significantly increased by 
104.9 % (p<0.01) at 100 km, the level insignificantly 
decreased by 98.1% at 200 km. However, the calcium 
level signifi  cantly decreased by 96.0% (p<0.01) at 308 km. 
Signifi  cant reductions of 93.5% (p<0.001) at 200 km and 
of 91.5% (p<0.001) at 308 km were observed compared 
to 100 km. A signifi  cant reduction of 97.9% (p<0.05) was 
also observed at 308 km compared to 200 km (Fig. 4). 
Changes in phosphate level for each checkpoint
  Although the phosphate level signifi  cantly increased by 
135.4% (p<0.001) at 100 km, comparatively no change 
of 100.0% was observed at 200 km and an insignificant 
reduction by 92.0 % was observed at 308 km. Signifi  cant 
reductions of 73.8% (p<0.001) and 67.9% (p<0.001) were 
observed at 200 km and 308 km, respectively, compared 
to 100 km, respectively. An insignificant reduction of 
92.0% was observed at 308 km compared to 200 km (Fig. 
5).
DISCUSSION
  The number of marathoners is ever-increasing despite 
extensive research on the risk of cartilage damage in 
marathon runners.
18 COMP is one of the protein com-
ponents within cartilage that gets released into the system 
Fig. 3. Changes in osteocalcin during the marathon. a: 
Significant difference compared to the pre-race value; 
c: significant difference compared to the 200-km value. 
††p<0.001 and 
†p<0.05.
Fig. 5. Changes in phosphorus during the marathon. a: 
Significant difference compared to the pre-race value; 
b: significant difference compared to the 100-km value. 
††p<0.001.
Fig. 4. Changes in calcium during the marathon. a: Signifi  cant 
difference compared to the pre-race value; b: significant 
difference compared to the 100-km point; c: significant 
difference compared to the 200-km value. ††p<0.001 and 
†p<0.05.Kyung-A Shin, et al.
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upon cartilage damage for increased activity in the blood. 
Increased blood COMP levels have been reported in 
most patients with degenerative or rheumatoid arthritis. 
Since COMP activity can be measured to predict cartilage 
damage and arthritis, it has been used as a predictive 
factor in the diagnosis of the current cartilage state as 
well as the degree of degeneration and progression.
19-21 
Neidhart et al.
4 reported that COMP levels were increased 
for at least for 3 weeks in individuals after running 
events compared to sedentary individuals. They also 
reported that COMP levels significantly increased 
upon completion of the marathon. Mündermann et 
al.
3 reported that increases in COMP were observed 30 
minutes after walking exercise. Moreover, Kersting et al.
2 
reported a correlation between COMP concentration 
and cartilage loss after 1 hour of running. In a study of a 
200-km ultra-marathon, Kim et al.
1 reported increased 
COMP concentrations by 1.3-fold at 100 km and 3.0-fold 
at 200 km. A similar increase of 130.7% at 100 km was also 
observed in this study. In addition, increases in COMP 
were observed at 200 km and 300 km by 160.4% and 
194.1%, respectively. Such results indicate the possibility 
of cartilage damage with increased COMP concentration.
  Circulating OPG is an important regulating factor in 
bone metabolism and a decoy receptor of RANKL, a key 
regulating factor of osteoclast differentiation. OPG is 
known to block RANKL by stimulating receptor activators 
of NF-κB (RANK) located on the surface of osteoclasts.
22 
Total OPG was measured by including RANKL-bound 
OPG and free OPG in this study. An increase in total OPG 
indicated an increase in RANKL-bound OPG. If free OPG 
levels are adequate, OPG will bind with RANKL without 
increasing free RANKL levels.
15 In addition, excessively 
increased RANKL may decrease active osteoclasts 
followed by a reduction in bone loss.
15 Kerschan-Schindl 
et al.
15 reported a signifi  cant increase in OPG expression 
upon completion of 246-km long distance running with 
a reduction tendency 3 days after the race compared to 
the pre-race OPG. Blood OPG levels were also measured 
at each checkpoint in this study. OPG significantly 
increased at 100 km and 200 km without significant 
changes at 308 km. OPG levels at each checkpoint 
increased until 100 km and significantly reduced 
thereafter. Although blood RANKL was not measured for 
osteoclast activation, Kerschan-Schindl et al.
15 reported 
increased RANKL levels upon completion until 3 days 
after the race. Based on such results, we estimated that 
the regulating function of OGP on osteoclasts increased 
until 100 km, followed by a tendency to decrease toward 
the 308-km checkpoint. However, an overall increase 
in OPG compared to pre-race OGP indicated stable 
maintenance of OPG until the end of the race. Although 
the discrepancy in results between the two studies is 
difficult to explain, it has been estimated based on the 
results that certain critical thresholds in exercise duration 
and distance exist that either negatively or positively 
aff  ect bone metabolism according to the distance run.
15 
Studies have measured such critical running points as 
being 80-100 km.
12,13 However, no other studies have 
divided the race distance by the checkpoints for specifi  c 
measurements in  threshold distance as in this study.
  OC is a non-collagen protein that formed by vitamin K 
within osteoblasts. It is important for bone metabolism 
turnover as a biochemical marker of osteogenesis. It 
is involved in bone mass and quality by combining 
with calcium for bone formation.
23 Research involving 
marathons and changes in OC measured blood OC 
before and immediately, 3, 6, and 24 hours after the race 
for recovery from a 21-km half marathon. Significant 
increases in OC were observed immediately after the race 
with a reduction to pre-race level 3 hours into recovery.
24 
In addition, average 20% and 10% reductions of OC were 
respectively observed in men and women immediately 
after the race, with the lowest OC levels observed 1 day 
after the race.
25 In ultra-marathon studies measuring the 
changes in bone metabolism turnover markers, bone-
forming markers such as OC, bone-alkaline phosphatase 
(b-ALP), type I procollagen C-propeptide (PICP), and 
calcium concentrations significantly increased. In 
addition, the carboxyterminal cross-linked telopeptide 
of type 1 collagen (ICTP), a bone resorption marker, 
was shown to significantly increase immediately after 
a 245-km marathon. Changes in OC, b-ALP, PICP, and 
calcium concentrations have been reported to be related 
to increase parathyroid hormone (PTH) and cortisol 
levels.
26
  OC was also significantly reduced immediately after 
a 246-km ultra-marathon compared to the pre-race 
measurement. However, OC significantly increased or 
recovered to the pre-race concentration 3 days after the 
race.
15 Although a signifi  cant change was not observed at 
100 km, a reduction tendency was observed. In addition, Eﬀ  ect of Ultra-marathon (308 km) Race on Bone and Cartilage
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OC was signifi  cantly reduced at 200 km compared to the 
pre-race values. Signifi  cantly increased OC levels at 308 
km compared with 200 km recovered to the initial OC 
concentration.
  Frost referred to the phenomenon of mechanical 
impairment as the mechanostat theory since the 
exercise loads determine bone metabolism promotion 
or inhibition. In other words, bone metabolism is not 
affected by exercise until it reaches certain mechanical 
load thresholds.
27,28 Th   erefore, although a certain amount 
of weight-bearing exercise improves bone density, 
excessive weight-bearing suppresses increases in bone 
density. Furthermore, MacDougall et al.
10 reported that 
the amount of salt concentration in professional long 
distance runners is lower than in non-athletes. Moreover, 
it was further revealed that weight-bearing exercise as the 
major endurance strengthening exercise can reversely 
aff  ect bone formation and density. 
  Other studies on bone metabolism markers reported 
that exercise loads activated bone metabolism and 
increased bone metabolism markers. On the other hand, 
Franck et al.
17 reported that weight-bearing exercise 
training done 2-3 times a week in young subjects led to a 
significant reduction in OC within 4 weeks, followed by 
recovery to the previous level in 8 weeks. It was suggested 
that such adaptation to exercise was due to an increase in 
PTH release and a decrease in OC production.
  In addition, Matsumoto et al.
11 reported lower levels of 
bone metabolism markers in male long distance runners. 
The possibility of increased bone response to exercise 
type and intensity over exercise frequency was also 
highlighted by the authors. Based on numerous studies 
such as the ones mentioned above, it was estimated that 
various OC thresholds exist according to the different 
distance covered by the runners. Bone formation was 
transiently suppressed by cortisol and PTH. Since studies 
have shown that RANKL, a marker of osteoclast activities, 
was continuously increased immediately and 3 days after 
the race,
15 it was estimated that both bone formation and 
resorption rates increased for higher bone metabolism 
turnover and increased OC instead of recovering to the 
pre-race state from 100 km to 308 km.
  Bourrin et al.
29 reported that a forced increase in exercise 
load leads to significantly reduced blood calcium and 
phosphate concentrations. The calcium concentration 
was significantly decreased compared to the pre-race 
value. Although statistically insignificant, a decreased 
tendency of the phosphate concentration was observed. 
It was suspected that such reductions in calcium and 
phosphate concentrations during the marathon were 
caused by an excessive loss of physical strength or an 
increased exercise load. Such physiological changes 
along with increased bone metabolism turnover may 
alter the use of calcium and phosphate as energy sources.
  Calcium and phosphate concentrations were measured 
at each checkpoint unlike the previous ultra-marathon 
race studies. Significant increases were observed at 
100 km compared to the pre-race value. Franck et 
al.
17 indicated an increase in PTH and a decrease in 
OC concentration during the adaptation stage of the 
exercise. Th   erefore, it was estimated that increased PTH 
and osteoclast activation may have increased calcium 
resorption through the bones or kidneys at 100 km.
  In summary, the possibility of cartilage damage 
progressively increased for all successive checkpoints. 
A temporary disassociation phenomenon of bone 
formation suppression and bone resorption promotion 
was observed until 200 km. Calcium and phosphate 
concentrations also increased with OC reduction until 
the initial 100 km. Increases in PTH and osteoclast 
activation have been suggested as being the major 
factors for such changes based on reported studies. It 
was further estimated that PTH and cortisol may have 
led to reduced OC and calcium concentrations. It was 
also suspected that accelerated bone formation and 
resorption for increased bone metabolism turnover may 
have recovered OC concentration to the pre-race state 
from 200 km until the end of the race. The osteoclast 
regulating ability of OPG was shown to increase until 
100 km. Although it may seem to decrease until the end, 
a certain stable concentration level was continuously 
maintained with a signifi  cant reduction seen at 200 km. 
Although the regulating ability of osteoclasts by OPG may 
require further study for clarifi  cation, the OPG regulation 
ability can be explained by diff  erent thresholds according 
to increased exercise loads.
  There are several study limitations that must be 
pointed out for future studies. One of the limitations 
would be the lack of bone resorption factor, one of the 
bone metabolism-related factors. To compensate for 
an absent factor, the results from other studies were 
referred. Although water was continuously supplied to Kyung-A Shin, et al.
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prevent the influence of increased blood concentration 
on the studied markers, the possible effect of blood 
concentration was not verified. A lack of test results on 
influencing factors such as RANKL, PTH, and cortisol 
may also be a study limitation. Finally, although the main 
focus of the study was the changes in bone metabolism 
markers before, during, and immediately after the race, 
the changes in these markers at diff  erent recovery times 
should be included in future studies to further clarify the 
changes in bone metabolism markers.
CONCLUSION
  We demonstrated that the possibility of cartilage 
damage increased as the running distance increased 
during a 308-km ultra-marathon. The effects on bone 
metabolism were observed by increased calcium and 
phosphate as well as decreased OC concentrations at 
100 km. Based on the results of various studies including 
ours, we estimated that PTH may have decreased the 
OC concentration. Reductions in both OC and calcium 
concentrations after the 100-km checkpoint were 
credited to the effects of cortisol and PTH. Increased 
bone metabolism turnover at 200 km or later has been 
suggested to recover OC concentration to the pre-race 
state. Th   e regulating ability of OPG on osteoclast tended 
to increase until 100 km but decreased thereafter. Despite 
the reduction in concentration, OPG was significantly 
increased compared to the pre-race value. Hence, the 
regulating ability of OPG was partially maintained. 
Signifi  cant reductions at 200 km and thereafter have been 
explained by reaching the threshold caused by increased 
exercise loads.
REFERENCES
1.  Kim HJ, Lee YH, Kim CK. Biomarkers of muscle and 
cartilage damage and infl  ammation during a 200 km 
run. Eur J Appl Physiol 2007; 99: 443-447
2.  Kersting UG, Stubendorff JJ, Schmidt MC, Brüggem-
man GP. Changes in knee cartilage volume and 
serum COMP concentration after running exercise. 
Osteoarthritis Cartilage 2005; 13: 925-934
3.  Mündermann A, Dyrby CO, Andriacchi TP, King KB. 
Serum concentration of cartilage oligomeric matrix 
protein (COMP) is sensitive to physiological cyclic 
loading in healthy adults. Osteoarthritis Cartilage 
2005; 13: 34-38
4.  Neidhart M, Muller-Ladner U, Frey W, Bosserhoff   AK, 
Colombani PC, Frey-Rindova P, Hummel KM, Gay RE, 
Hauselmann H, Gay S. Increased serum levels of non-
collageneous matrix proteins (cartilage oligomeric 
matrix protein and melanoma inhibitory activity) in 
marathon runners. Osteoarthritis Cartilage 2000; 8: 
222-229
5.  Wong M, Carter DR. Articular cartilage functional 
histomorphology and mechanobiology: a research 
perspective. Bone 2003; 33: 1-13
6.  Nieman DC, Henson DA, Smith LL, Utter AC, Vinci 
DM, Davis JM, Kaminsky DE Shute M. Cytokine 
changes after a marathon race. J Appl Physiol 2001; 
91: 109-114
7.  Nieman DC, Dumke CL, Henson DA, McAnulty 
SR, Gross SJ, Lind RH. Muscle damage is linked to 
cytokine changes following a 160-km race. Brain 
Behav Immun 2005; 19: 398-403
8.  Suzuki K, Yamada M, Kurakake S, Okamura N, 
Yamada K, Liu Q, Kudoh S, Kowatari K, Nakaji S, 
Suga  wara K. Circulating cytokines and hormones with 
immuno  suppressive but neutrophil-priming poten-
tials rise after endurance exercise in humans. Eur J 
Appl Physiol 2000; 81: 281-287
9.  Eckstein F, Lemberger B, Gratzke C, Hudelmaier M, 
Glaser C, Englmeier KH, Reiser M. In vivo cartilage 
deformation after different types of activity and its 
dependence on physical training status. Ann Rheum 
Dis 2005; 64: 291-295
10. MacDougall JD, Webber CE, Martin J, Ormerod S, 
Chesley A, Younglai EV, Gordon CL, Blimkie CJ. 
Relationship among running mileage, bone density, 
and serum testosterone in male runners. J Appl 
Physiol 1992; 73: 1165-1170
11. Matsumoto T, Nakagawa S, Nishida S, Hirota R. 
Bone density and bone metabolic markers in active 
collegiate athletes: fi  ndings in long-distance runners, 
judoists, and swimmers. Int J Sports Med 1997; 18: 
408-412
12. Burrows M, Nevill AM, Bird S, Simpson D. Physio-
logical factors associated with low bone mineral 
density in female endurance runners. Br J Sports Med 
2003; 37: 67-71
13. De Souza MJ, Miller BE. The effect of endurance Eﬀ  ect of Ultra-marathon (308 km) Race on Bone and Cartilage
87 www.e-arm.org
training on reproductive function in male runners. A 
‘volume threshold’ hypothesis. Sports Med 1997; 23: 
357-374
14. Rogers A, Eastell R. Circulating osteoprotegerin and 
receptor activator for nuclear factor kappaB ligand: 
clinical utility in metabolic bone disease assessment. 
J Clin Endocrinol Metab 2005; 90: 6323-6331
15. Kerschan-Schindl K, Thalmann M, Sodeck GH, 
Skenderi K, Matalas AL, Grampp S, Ebner C, Piets-
chmann P. A 246-km continuous running race causes 
significant changes in bone metabolism. Bone 2009; 
45: 1079-1083
16. Calvo MS, Eyre DR, Gundberg CM. Molecular basis 
and clinical application of biological markers of bone 
turnover. Endocr Rev 1996; 17: 333-368
17. Franck H, Beuker F, Gurk S. The effect of physical 
activity on bone turnover in young adults. Exp Clin 
Endocrinol 1991; 98: 42-46
18. Tosch U, Sander B, Schubeus P, Eckart L, Felix R. 
Magnetic resonance tomographic and sonographic 
imaging of the ankle in marathon runners. Rofo 1991; 
154: 150-154
19. Hedbom E, Antonsson P, Hjerpe A, Aeschlimann D, 
Paulsson M, Rosa-Pimentel E, Sommarin Y, Wendel 
M, Oldberg A, Heinegard D. Cartilage matrix proteins. 
An acidic oligomeric protein (COMP) detected only in 
cartilage. J Biol Chem 1992; 267: 6132-6136
20. Skoumal M, Kolarz G, Klingler A. Serum levels of 
cartilage oligomeric matrix protein. A predicting factor 
and a valuable parameter for disease management 
in rheumatoid arthritis. Scand J Rheumatol 2003; 32: 
156-161
21. Sharif M, Kirwan JR, Elson CJ, Granell R, Clarke S. 
Suggestion of nonlinear or phasic progression of 
knee osteoarthritis based on measurements of serum 
cartilage oligomeric matrix protein levels over five 
years. Arthritis Rheum 2004; 50: 2479-2488
22. Schoppet M, Preissner KT, Hofbauer LC. RANK 
ligand and osteoprotegerin: paracrine regulators of 
bone metabolism and vascular function. Arterioscler 
Th   romb Vasc Biol 2002; 22: 549-553
23. Shiraki M, Aoki C, Goto M. Bone and calcium meta-
bolism in Werner’s syndrome. Endocr J 1998; 45: 505-
512
24. Lippi G, Schena F, Montagnana M, Salvagno GL, 
Banfi   G, Guidi GC. Acute variation of osteocalcin and 
parathyroid hormone in athletes after running a half-
marathon. Clin Chem 2008; 54: 1093-1095
25. Malm HT, Ronni-Sivula HM, Viinikka LU, Ylikorkala 
OR. Marathon running accompanied by transient 
decreases in urinary calcium and serum osteocalcin 
levels. Calcif Tissue Int 1993; 52: 209-211
26.  Mouzopoulos G, Stamatakos M, Tzurbakis M, 
Tsembeli A, Manti C, Safioleas M, Skandalakis P. 
Changes of bone turnover markers after marathon 
running over 245 km. Int J Sports Med 2007; 28: 576-
579
27. Frost HM. The mechanostat: a proposed pathogenic 
mechanism of osteoporoses and the bone mass eff  ects 
of mechanical and nonmechanical agents. Bone 
Miner 1987; 2: 73-85
28. Frost HM. Bone “mass” and the “mechanostat”: a 
proposal. Anat Rec 1987; 219: 1-9
29. Bourrin S, Ghaemmaghami F, Vico L, Chappard 
D, Gharib, C, Alexandre C. Effect of a five-week 
swimming program on rat bone: a histomorphometric 
study. Calcif Tissue Int 1992; 51: 137-142